SCHEDULE: Harbert Fund Reduces Stake in TransAct Technologies Below 5%

Sentiment:

Beneficial Ownership Amendment


Harbert Discovery Fund and its affiliates have reported reducing their beneficial ownership in TransAct Technologies Inc. to 4.3%, falling below the 5% threshold.

Summary

  • Harbert Discovery Fund, LP, along with its affiliates and associated individuals (collectively, the "Reporting Persons"), filed an Amendment No. 6 to their Schedule 13D.
  • The amendment reports that as of September 22, 2025, the Reporting Persons no longer beneficially own more than 5% of TransAct Technologies Inc.'s outstanding Common Stock.
  • The Reporting Persons now beneficially own 429,993 shares, which represents 4.3% of the Issuer's Common Stock.
  • This percentage is based on 10,092,326 shares outstanding as of July 31, 2025, as reported by TransAct Technologies Inc. in its Form 10-Q.
  • The shares were acquired using working capital of the Fund; no borrowed funds were used for the purchase, other than for ordinary course working capital purposes.
  • Transactions since the last Schedule 13D filing on September 4, 2025, primarily involved dispositions (sales) of Common Stock, with prices ranging from $4.49 to $5.42 per share between September 5, 2025, and September 24, 2025.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative as a significant institutional investor has reduced its stake below the 5% threshold, which can be interpreted as a decrease in confidence or a strategic divestment, potentially impacting investor perception of the company.

Negatives

  • A significant institutional investor reducing its stake below the 5% reporting threshold could be perceived by the market as a signal of reduced conviction or a shift in investment strategy regarding TransAct Technologies Inc.

Future Outlook

The filing does not provide any forward-looking statements or guidance from TransAct Technologies Inc. or the Reporting Persons regarding the Issuer's future performance.

Industry Context

This filing primarily concerns a change in institutional ownership and does not provide specific insights into broader industry trends or competitive landscape for TransAct Technologies Inc.

Stakeholder Impact

  • Shareholders: May interpret the reduction in institutional ownership as a negative signal, potentially affecting investor confidence and share price.
  • Investment Community: Analysts and other investors may scrutinize the reasons behind Harbert Discovery Fund's reduced stake, potentially leading to re-evaluation of their own positions.

Key Dates

DateDescription
2025-07-31Date of outstanding shares figure (10,092,326) as reported by the Issuer in its Quarterly Report on Form 10-Q.
2025-09-04Date of the last Schedule 13D filed by the Reporting Persons.
2025-09-05Date of first reported transaction (disposition of 5,000 shares at $4.49).
2025-09-08Date of transaction (disposition of 17,065 shares at $4.57).
2025-09-09Date of transaction (disposition of 10,000 shares at $4.62).
2025-09-10Date of transaction (disposition of 394 shares at $4.70).
2025-09-11Date of transaction (disposition of 5,000 shares at $4.66).
2025-09-15Date of transaction (disposition of 15,529 shares at $4.60).
2025-09-16Date of transaction (disposition of 1,419 shares at $4.65).
2025-09-17Date of transaction (disposition of 5,100 shares at $4.66).
2025-09-18Date of transaction (disposition of 5,000 shares at $4.70).
2025-09-19Date of transaction (disposition of 10,872 shares at $4.80).
2025-09-22Date when Reporting Persons no longer beneficially owned more than 5% of the Issuer's outstanding shares (also date of transaction: disposition of 25,611 shares at $5.10).
2025-09-23Date of transaction (disposition of 7,353 shares at $5.41).
2025-09-24Date of transaction (disposition of 1,759 shares at $5.42) and date of signing of the Schedule 13D amendment and Joint Filing Agreement.

Recommendation

hold

The reduction in a significant institutional investor's stake below the 5% threshold, as reported by Harbert Discovery Fund, suggests a potential shift in their investment thesis or a reallocation of capital. While not an operational update from TransAct Technologies Inc. itself, such a move by a major holder can signal reduced conviction. Investors should 'hold' and monitor for further developments or explanations from the company, as this action alone does not provide sufficient grounds for a 'buy' or 'sell' recommendation without additional fundamental analysis of the company's performance and outlook.

Keywords

TransAct Technologies, Harbert Discovery Fund, Beneficial Ownership, Stake Reduction, SEC Filing, Schedule 13D, Common Stock, Institutional Investor

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.